Published :
Tables : 46
Figures : 46
Category : Healthcare
No. of Pages : 205
Report Code : HC-U3971
Exoskeleton Market is poised to value over USD 4.1 billion by 2027 end at a CAGR of over 45% during the forecast period 2020 to 2027. FutureWise Market Research has instantiated a report that provides a comprehensive analysis of Exoskeleton Market trends that influence the overall market growth. Furthermore, it includes elaborative insights on the graph of profitability, SWOT analysis, market share and regional business growth. Moreover, the report offers apprehension on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Exoskeleton Market is predicted to achieve substantial growth by the end of the forecast period. The report explains that this business is anticipated to record a noteworthy growth rate over the forecasted timeframe. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also includes a thorough list of market segmentations along with the growth opportunities across this business vertical. Major players included in the Exoskeleton Market: • ReWalk Robotics Ltd. • Ekso Bionics • Rex Bionics Plc • Suit X (U.S. Bionics Inc.) • Lockheed Martin Corporation • Hocoma • Parker Hannifin Corporation • Hyundai Motor Company • Axiobionics • Myomo, Inc. • Honda Motor Co. Ltd. • Technaid. S.L. • Gogoa Mobility Robots SL • Wearable Robotics SRL • DIH Technologies Corporation (Note: The list of the major players will be updated with the latest market scenario and trends) Exoskeleton Market Segmentation: By Component • Hardware o Sensor o Actuator o Power Source o Control System/Controller o Others (Body Material and other Electronic, Electrical, and Mechanical Components) • Software By Type • Powered • Passive By Mobility • Stationary • Mobile By Body Part • Lower Extremities • Upper Extremities • Full Body By Vertical • Healthcare • Defense • Industrial • Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness) By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Exoskeleton Market By Component,By Type,By Mobility,By Body Part,By Vertical and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions Flexible Model: • We have a flexible Model and you can suggest changes in the scope/table of content as per your requirement • The customisations offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides a comprehensive analysis of Exoskeleton Market trends that influence the overall market growth. Furthermore, it includes elaborative insights on the graph of profitability, SWOT analysis, market share and regional business growth. Moreover, the report offers apprehension on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Exoskeleton Market is predicted to achieve substantial growth by the end of the forecast period. The report explains that this business is anticipated to record a noteworthy growth rate over the forecasted timeframe. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also includes a thorough list of market segmentations along with the growth opportunities across this business vertical.
Major players included in the Exoskeleton Market: • ReWalk Robotics Ltd. • Ekso Bionics • Rex Bionics Plc • Suit X (U.S. Bionics Inc.) • Lockheed Martin Corporation • Hocoma • Parker Hannifin Corporation • Hyundai Motor Company • Axiobionics • Myomo, Inc. • Honda Motor Co. Ltd. • Technaid. S.L. • Gogoa Mobility Robots SL • Wearable Robotics SRL • DIH Technologies Corporation (Note: The list of the major players will be updated with the latest market scenario and trends)
Exoskeleton Market Segmentation: By Component • Hardware o Sensor o Actuator o Power Source o Control System/Controller o Others (Body Material and other Electronic, Electrical, and Mechanical Components) • Software
By Type • Powered • Passive
By Mobility • Stationary • Mobile
By Body Part • Lower Extremities • Upper Extremities • Full Body
By Vertical • Healthcare • Defense • Industrial • Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness)
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Exoskeleton Market By Component,By Type,By Mobility,By Body Part,By Vertical and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions
Flexible Model: • We have a flexible Model and you can suggest changes in the scope/table of content as per your requirement • The customisations offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Exoskeleton Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Of Administration Overview 4.6. Dermatology Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Exoskeleton Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Dermatology Framework 6. Global Exoskeleton Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Drive Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Drive Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Exoskeleton Market, By Component Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Hardware 7.1.1. Sensor 7.1.2. Actuator 7.1.3. Power Source 7.1.4. Control System/Controller 7.1.5. Others (Body Material and other Electronic, Electrical, and Mechanical Components) 7.2. Software 8. Global Exoskeleton Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Powered 8.2. Passive 9. Global Exoskeleton Market,By Mobility Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Stationary 9.2. Mobile 10. Global Exoskeleton Market, By Body Part Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Lower Extremities 10.2. Upper Extremities 10.3. Full Body 11. Global Exoskeleton Market, By Vertical Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Healthcare 11.2. Defense 11.3. Industrial 11.4. Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness) 12. North America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027 15. Asia Pacific Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 18.1. ReWalk Robotics Ltd. 18.1.1. Company Overview 18.1.2. Type Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Ekso Bionics 18.2.1. Company Overview 18.2.2. Type Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Rex Bionics Plc 18.3.1. Company Overview 18.3.2. Type Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Suit X (U.S. Bionics Inc.) 18.4.2. Type Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Lockheed Martin Corporation 18.5.1. Company Overview 18.5.2. Type Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Hocoma 18.6.1. Company Overview 18.6.2. Type Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Parker Hannifin Corporation 18.7.1. Company Overview 18.7.2. Type Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Hyundai Motor Company 18.8.1. Company Overview 18.8.2. Type Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Axiobionics 18.9.1. Company Overview 18.9.2. Type Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. Myomo, Inc. 18.10.1. Company Overview 18.10.2. Type Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Honda Motor Co. Ltd. 18.11.1. Company Overview 18.11.2. Type Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. Technaid. S.L. 18.12.1. Company Overview 18.12.2. Type Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13. Gogoa Mobility Robots SL 18.13.1. Company Overview 18.13.2. Type Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14. Wearable Robotics SRL 18.14.1. Company Overview 18.14.2. Type Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15. DIH Technologies Corporation 18.15.1. Company Overview 18.15.2. Type Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Exoskeleton Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Type Of Administration Overview 4.6. Dermatology Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Exoskeleton Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Dermatology Framework
6. Global Exoskeleton Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Drive Type Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Drive Type Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Exoskeleton Market, By Component Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Hardware 7.1.1. Sensor 7.1.2. Actuator 7.1.3. Power Source 7.1.4. Control System/Controller 7.1.5. Others (Body Material and other Electronic, Electrical, and Mechanical Components) 7.2. Software
8. Global Exoskeleton Market,By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Powered 8.2. Passive 9. Global Exoskeleton Market,By Mobility Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Stationary 9.2. Mobile 10. Global Exoskeleton Market, By Body Part Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Lower Extremities 10.2. Upper Extremities 10.3. Full Body
11. Global Exoskeleton Market, By Vertical Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Healthcare 11.2. Defense 11.3. Industrial 11.4. Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness)
12. North America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027
13. Latin America Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027
14. Europe Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027
15. Asia Pacific Exoskeleton Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 18.1. ReWalk Robotics Ltd. 18.1.1. Company Overview 18.1.2. Type Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Ekso Bionics 18.2.1. Company Overview 18.2.2. Type Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Rex Bionics Plc 18.3.1. Company Overview 18.3.2. Type Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Suit X (U.S. Bionics Inc.) 18.4.2. Type Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Lockheed Martin Corporation 18.5.1. Company Overview 18.5.2. Type Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Hocoma 18.6.1. Company Overview 18.6.2. Type Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Parker Hannifin Corporation 18.7.1. Company Overview 18.7.2. Type Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Hyundai Motor Company 18.8.1. Company Overview 18.8.2. Type Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Axiobionics 18.9.1. Company Overview 18.9.2. Type Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. Myomo, Inc. 18.10.1. Company Overview 18.10.2. Type Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Honda Motor Co. Ltd. 18.11.1. Company Overview 18.11.2. Type Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. Technaid. S.L. 18.12.1. Company Overview 18.12.2. Type Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13. Gogoa Mobility Robots SL 18.13.1. Company Overview 18.13.2. Type Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14. Wearable Robotics SRL 18.14.1. Company Overview 18.14.2. Type Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15. DIH Technologies Corporation 18.15.1. Company Overview 18.15.2. Type Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics